Gilead and Merck Report Successful Phase 2 Results for Investigational Once-Weekly HIV Treatment
The combination of the antiviral agents islatravir and lenacapavir demonstrates both efficacy and safety, leading to advancement into Phase 3 trials.
Related Articles
COVID 5 years later: Learning from a pandemic many are forgetting
Five years after SARS-CoV-2 surfaced, scientists reflect and look ahead to the next threat
Best biosecurity coverage of 2024
In 2024, the Bulletin covered zombie pathogens emerging from a thawing Arctic, synthetic viruses, the pandemic that crippled ancient Rome, and more. Here are some…
Strategic Report on Research and Development in Biotechnology for Defense Innovation
Read online, download a free PDF, or order a copy in print.
Are we ready for another pandemic?
After Covid-19, world leaders agreed to work together to strengthen global health systems, but negotiations on a new agreement have stalled
COVID 5 years later: Learning from a pandemic many are forgetting
Five years after SARS-CoV-2 surfaced, scientists reflect and look ahead to the next threat
A riot for impunity shows Israel’s proud embrace of its crimes
Far-right protesters, soldiers, and MKs rallied for guards suspected of raping a detainee. Once fringe, they’re now the public face of the state.
U.S. decries reported sexual abuse of Palestinian prisoners after graphic video aired on Israeli TV
“We have seen the video, and reports of sexual abuse of detainees are horrific,” State Department spokesperson Matthew Miller said.
Israeli military doctor reveals shocking conditions in Sde Teiman detention center
‘To hold a person without letting them move any of their limbs, blindfolded, naked, under treatment, in the middle of desert, … in the end,…
Virologic failure and emergent integrase strand transfer inhibitor drug resistance with long acting cabotegravir for HIV treatment: A meta-analysis
Although 48-week virological failure rates were low, emergent integrase resistance among those failing injectable cabotegravir was common (41-71%), and cro
US norovirus outbreaks are up, CDC data show
Health departments in 14 states reported 91 norovirus outbreaks in the first week of December.
